The following is a summary of “Feasibility of trancutaneous auricular vagus nerve stimulation in Black and Hispanic/Latino people with peripheral neuropathy,” published in the January 2025 issue of ...

A very small 2022 report also suggests that TENS shows promise in the treatment of diabetic peripheral neuropathy. Researchers looked at the effects of a ReBuilder TENS and electronic muscle ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...

"FDA approves Vertex’s acute pain treatment Journavx" was originally created and published by Pharmaceutical Technology, a ...

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

Just over a year after its first phase 3 trial of its Engensis gene therapy for painful diabetic peripheral neuropathy (DPN ... At the moment treatment is limited to drugs like gabapentin and ...

Azoles. Used to treat fungal infections, azoles have been linked to peripheral neuropathy. Metformin. This commonly used diabetes drug may cause peripheral neuropathy, possibly because it leads to ...

GP Dr Roger Henderson provides an overview of the chronic complications of diabetes and the key preventive measures ...

Blood tests may be necessary to check for diabetes, thyroid function ... Academy of Family Physicians recommends that peripheral neuropathy treatment address the underlying disease process ...

People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...

The FDA approves Vertex's non-opioid oral pain signal inhibitor, Journavx, for treating adults with moderate-to-severe acute pain. Shares rise.